Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens
US-12576148-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Kaiser Andrew patents
Kaiser Andrew is listed as an inventor on 35 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kaiser Andrew |
| Total patents | 35 |
| First publication | May 26, 2016 |
| Latest publication | Mar 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Hematopoietic cells with a modified CD antigen for reducing side effects of cancer immunotherapy
US-12521434-B2 · Jan 13, 2026 · US
A system for drug-inducible expression of a polynucleotide
US-2025255959-A1 · Aug 14, 2025 · US
Method for targeted gene insertion into immune cells
US-2025235477-A1 · Jul 24, 2025 · US
Adapter-based retroviral vector system for the selective transduction of target cells
US-12365916-B2 · Jul 22, 2025 · US
Reducing side effects of immunotherapy using genetically modified hematopoietic cells
US-12318446-B2 · Jun 3, 2025 · US
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen
US-12246065-B2 · Mar 11, 2025 · US
Regulatory T cell expressing a chimeric antigen receptor
US-12178872-B2 · Dec 31, 2024 · US
Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens
US-2024316192-A1 · Sep 26, 2024 · US
Reducing side effects of immunotherapy using genetically modified hematopoietic cells
US-2024307533-A1 · Sep 19, 2024 · US
Recent patents
Latest publications not already listed above.
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen
US-2024269275-A1 · Aug 15, 2024 · US
CD62L specific lentiviral vector particle for targeted transduction of T cell subsets
US-12018273-B2 · Jun 25, 2024 · US
Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
US-11890300-B2 · Feb 6, 2024 · US
Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered form
US-11883494-B2 · Jan 30, 2024 · US
System for inducible expression of an adapter in immune cells
US-2023313206-A1 · Oct 5, 2023 · US
Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered form
US-2023248823-A1 · Aug 10, 2023 · US
Immune cell expressing adapter chimeric antigen receptor for sensing soluble antigens
US-2023100000-A1 · Mar 30, 2023 · US
Method for Transduction of T Cells in the Presence of Malignant Cells
US-2022315894-A1 · Oct 6, 2022 · US
Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cells
US-11419935-B2 · Aug 23, 2022 · US
Method for Generation of Genetically Modified T Cells
US-2022220504-A1 · Jul 14, 2022 · US
A Combination of compositions for elimination and enhanced engraftment of hematopoietic stem cells in the bone marrow of a subject
US-2022133791-A1 · May 5, 2022 · US
Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cells
US-2021401980-A1 · Dec 30, 2021 · US
Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form
US-2021338814-A1 · Nov 4, 2021 · US
Use of a car cell having crosslinked disulfide bridge on antigen recognizing moiety for targetting cancer cells
US-2021275586-A1 · Sep 9, 2021 · US
Adapter-based retroviral vector system for the selective transduction of target cells
US-2021180083-A1 · Jun 17, 2021 · US
Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form
US-11033619-B2 · Jun 15, 2021 · US
Regulatory T Cell Expressing a Chimeric Antigen Receptor
US-2020353004-A1 · Nov 12, 2020 · US
Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
US-2019388468-A1 · Dec 26, 2019 · US
Adapter chimeric antigen receptor expressing cells for targeting of multiple antigens
US-2019315879-A1 · Oct 17, 2019 · US
Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases
US-10201606-B2 · Feb 12, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Miltenyi Biotec Bv & Co Kg | 27 |
| Miltenyi Biotec Gmbh | 11 |
| Univ Berlin Charite | 2 |
| Charite—Universitaetsmedizin Berlin | 1 |
| Mitenyi Biotec B V & Co Kg | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K40/11 | 31 |
| A61K40/31 | 30 |
| A61K40/4221 | 22 |
| A61K2039/5156 | 21 |
| A61P35/00 | 20 |